Theisen, M <br/><br/>
Selection of glutamate-rich protein long synthetic peptides for vaccine development: antigenicity and relationship with clinical protection and immunogenicity.  [electronic resource] 

 -  Infection and immunity  Sep 2001 
 - 5223-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0019-9567 
<br/><br/><label>Standard No.: </label>10.1128/IAI.69.9.5223-5229.2001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Animals<br/>Antibodies, Protozoan--blood<br/>Antigens, Protozoan--immunology<br/>Child<br/>Child, Preschool<br/>Female<br/>Humans<br/>Malaria Vaccines--immunology<br/>Malaria, Falciparum--prevention & control<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Inbred CBA<br/>Mice, Inbred DBA<br/>Middle Aged<br/>Peptides--chemical synthesis<br/>Plasmodium falciparum--immunology<br/>Protozoan Proteins--chemistry<br/>T-Lymphocytes--immunology